As shown in Figure 6C, JQ1 and Vorinostat significantly inhibited Cluster2A (IDH1 mutant) ICC cells, but not Cluster1A (KRAS/TP53 mutant) ICC cells. This evidence concerns the gene KRAS and intrahepatic cholangiocarcinoma.